MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

HOUSTON, June 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

TECregen seed funding supports the development of thymus regeneration biologics designed to restore immune function and ...

Researchers have used pluripotent stem cells to make thymus organoids that support the development of patient-specific T-cells, researchers report March 23 rd in the journal Stem Cell Reports. The ...

Scientists hoping to discover better ways to boost immune function — which could lengthen our healthspan and protect immunocompromised patients — may have a new target, according to findings published ...

Swiss biotech TECregen has raised 10 million Swiss francs ($12.6 million) in seed financing to advance its thymus ...

Researchers have for the first time identified all genes regulated by the protein Foxn1. The results show that Foxn1 not only plays a crucial role in development of the thymus in the embryo, but it ...

The Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services, has announced up to $37 million to restore function to the thymus through funding ...